Zions Bancorporation, N.A. Abb Vie Inc. Transaction History
Zions Bancorporation, N.A.
- $1.58 Billion
- Q4 2024
A detailed history of Zions Bancorporation, N.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 50,232 shares of ABBV stock, worth $9.23 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
50,232
Previous 29,672
69.29%
Holding current value
$9.23 Million
Previous $5.86 Million
52.35%
% of portfolio
0.57%
Previous 0.43%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
4,270Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.7 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.1 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.56 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $325B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...